Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
2.420
+0.070 (2.98%)
At close: Oct 8, 2025, 4:00 PM EDT
2.380
-0.040 (-1.66%)
After-hours: Oct 8, 2025, 7:07 PM EDT
Phio Pharmaceuticals Employees
Phio Pharmaceuticals had 5 employees as of December 31, 2024. The number of employees decreased by 4 or -44.44% compared to the previous year.
Employees
5
Change (1Y)
-4
Growth (1Y)
-44.44%
Revenue / Employee
n/a
Profits / Employee
-$1,417,000
Market Cap
13.86M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5 | -4 | -44.44% |
| Dec 31, 2023 | 9 | -1 | -10.00% |
| Dec 31, 2022 | 10 | -2 | -16.67% |
| Dec 31, 2021 | 12 | 2 | 20.00% |
| Dec 31, 2020 | 10 | -1 | -9.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PHIO News
- 15 days ago - Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series - Newsfile Corp
- 20 days ago - Phio Pharmaceuticals to Present at the Life Sciences Future Conference - Newsfile Corp
- 5 weeks ago - Phio Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Newsfile Corp
- 7 weeks ago - Phio Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update - Newsfile Corp
- 2 months ago - Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross Proceeds - Newsfile Corp
- 2 months ago - Phio Pharmaceuticals Announces Pathology Results for Four of Five Patients in Fourth Cohort - Newsfile Corp
- 2 months ago - Phio Pharmaceuticals Announces Agreement with U.S. Manufacturing Source for Drug Substance - Newsfile Corp
- 3 months ago - Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Clinical Trial to Fifth Dose Escalation Cohort - Newsfile Corp